Patients were grouped according to the GPA, they found that patients with acquired EGFR TKI-resistance have a poor OS (78.9 vs. 19.5 months, p < 0.01) than TKI-naïve patients in GPA 2.5–4 group [29]. The gene discussed is EGFR; the disease is granulomatosis with polyangiitis.